The physical health of people with schizophrenia is poor, and associated with increased morbidity and mortality. Unhealthy lifestyles and side-effects of antipsychotic medication contribute to cardiometabolic dysfunction. Yet it is unclear when this unhealthy profile starts. We aimed to see if people at ultra-high risk for psychosis (UHR) have increased rates of cardiometabolic risk factors. Method: An electronic search of MEDLINE, PsycINFO, Embase and the Cochrane Central Register of Controlled Trials was conducted on 1st May 2015 using terms associated with the ultra-high risk state and health. Eligible studies were peer-reviewed English language research articles with populations that met at-risk diagnostic criteria and reported cardiometabolic risk factors. A meta-analysis was conducted on smoking data, the cardiometabolic risk factor that yielded the most studies. Results: Forty-seven eligible studies were identified. UHR samples had low levels of physical activity, and high rates of smoking and alcohol abuse compared with controls. No differences were found for body mass index. An overall pooled rate of smoking for UHR participants was 33% (95% CI = 0.24-0.42) and significantly more UHR individuals smoked compared with controls with a pooled odds ratio of 2.3 (P b 0.05; 95% CI = −1.48-3.48). Conclusions: UHR samples display cardiometabolic risk factors which are largely modifiable. The UHR phase is an important opportunity for early intervention services to improve physical health. 
Introduction
The physical health of people with schizophrenia is poor. They are at 2.5 times the risk of premature mortality and their life expectancy is 10 to 30 years lower than the general population (De Hert et al., 2011a; Saha et al., 2007; Wahlbeck et al., 2011) . Despite advances in health care and pharmaceutical developments, the life expectancy gap continues to widen (Saha et al., 2007) . A leading cause of premature mortality is cardiovascular disease, arising from increased rates of cardiometabolic risk factors such as obesity, hypertension, hyperglycaemia, and dyslipidaemia (Hennekens et al., 2005; Mitchell et al., 2013) , as well as high rates of smoking (Control and Prevention, 2013; Krishnadas et al., 2012; McCreadie, 2003) and alcohol consumption (Addy et al., 2012; Drake and Mueser, 2002) , poor diet (McCreadie, 2003) and low levels of physical activity (Daumit et al., 2005; Vancampfort et al., 2011) .
The cause or causes of this poor cardiometabolic health is unclear. There is evidence of hyperglycaemia, dyslipidaemia and weight gain during the first episode of psychosis, within the first few weeks after initiating antipsychotic treatment (Correll et al., 2014; De Hert et al., 2006; Foley and Morley, 2011) . Metabolic abnormalities increase considerably with illness duration (De Hert et al., 2006 , 2011b . There is also evidence that antipsychotic-naïve individuals with non-affective psychosis have abnormal glucose tolerance (Fernandez-Egea et al., 2009) , as do first-degree relatives of people with schizophrenia (Baptista et al., 2011; Spelman et al., 2007) . This has led to the suggestion that cardiometabolic risk factors may be inherent to illness progression, and enhanced by antipsychotic medication (De Hert et al., 2006) . Determining whether these factors are present before the onset of disorder and antipsychotic prescription could inform this debate.
One way this issue can be studied further is to consider the physical health of people prior to psychosis onset. The ultra-high risk (UHR) state (also known as the clinical high-risk (CHR) and at-risk mental state (ARMS) (Fusar-Poli et al., 2013) ) allows the identification of people in the putative prodrome for psychosis (Miller et al., 2002; Yung et al., 1996) . In order to meet UHR status an individual must exhibit one or a combination of the following characteristics: presence of attenuated psychotic symptoms, brief limited intermittent psychotic symptoms which spontaneously resolve or genetic-risk combined with recent decline in functioning (Yung et al., 2004) . Approximately 30% of UHR individuals transition to full-threshold psychotic disorders within three years, and a large proportion of these individuals will develop schizophrenia (Nelson et al., 2013) . These criteria have important implications for early intervention and allow us to examine the physical and psychological health of young people prior to onset of psychotic disorder.
We aimed to systematically review the literature to examine: (1) The prevalence of cardiometabolic risk factors in UHR populations; (2) Whether these cardiometabolic risk factors are related to psychological variables.
Method
This review was conducted according to PRISMA guidelines for reporting systematic reviews (Moher et al., 2009 ).
Eligibility criteria
Eligible studies were original research articles published in peerreviewed journals, with populations meeting diagnostic criteria for 'atrisk', 'ultra-high risk' or 'clinical-high risk' (or similarly defined) of psychosis, based on a clinically validated instrument (Daneault and Stip, 2013) . Studies reporting on either clinical or behavioural cardiometabolic risk factors within this population were included. Clinical assessments included body mass index (BMI), weight, blood pressure (BP), blood glucose and lipid levels. Behavioural cardiometabolic risk factors included tobacco and alcohol use, physical activity, fitness levels, and diet. Retrospective, cross-sectional and longitudinal studies were eligible. Intervention studies were included when relevant baseline measures were reported.
Studies including only subjects at genetic-risk, not meeting formal diagnostic criteria for being at-risk of psychosis were excluded, as were case studies, reviews and non-English language articles. When study samples overlapped across publications, the larger sample was included in the review. Studies reporting data solely relating to neuroimaging or neurotransmitters were excluded, as these are seen as a biomarker or psychosis endophenotype and not necessarily a marker of physical health.
Search strategy
An electronic database search was conducted on 1st May 2015 using Ovid MEDLINE, Embase, PsycINFO and the Cochrane Central Register of Controlled Trials (CENTRAL). The following keyword search terms were used: 'clinical high risk' or 'CHR' or 'ultra high risk' or 'UHR' or 'at risk mental state' or 'ARMS' or 'prodrom*' and 'psychos*' or 'psychot*' or 'schizo*' and 'health*'. The broad search term 'health*' was used to ensure that the maximum number of potential studies were retrieved, given the broad nature of the research topic. Reference lists of retrieved papers were hand searched, and experts in the field were contacted to identify additional relevant publications.
Study selection and data extraction
Three reviewers (R.C., J.C. and J.F.) independently screened articles for eligibility. Disagreements were resolved through discussion. A tool was developed to record: (1) study characteristics (author, year of publication, country of origin, study design); (2) sample demographics (sample size, gender, mean age); (3) instrument used to assess at-risk status; (4) cardiometabolic risk factors (measure, sample mean or prevalence reported); (5) psychological variables associated with cardiometabolic risk factors; and (6) summary of findings. Data extracted was grouped into specific risk factors, and narrative synthesis was conducted.
Meta-analysis
We also aimed to determine the prevalence of cardiometabolic risk factors in UHR samples, and compare this to healthy controls. Metaanalytic methods were applied to the most commonly reported risk factor, which was smoking. Individual study data for smoking prevalence among UHR individuals were pooled using proportional meta-analysis in StatsDirect 2.8 (StatsDirect, 2005) . Additionally, an odds ratio metaanalysis was used to compare the rates of smoking in UHR with healthy controls. The amount of variance between studies was examined using Cochran's Q, and indexed using I 2 (which estimates the extent of variance caused by between-study heterogeneity rather than chance). A DerSimonian and Laird (1986) random-effects model was applied to all analyses to account for heterogeneity between studies (DerSimonian and Laird, 1986).
Results

Search results
The study selection and exclusion process is summarised in Fig. 1 . Database searches retrieved 2281 unique citations after removal of duplicates, of which 1909 were excluded at the title-abstract stage and a further 327 after full-paper review. Full text articles were excluded if they did not examine cardiometabolic risk factors (n = 290), included an ineligible population (n = 7), were review papers or case studies (n = 23) or had an overlapping sample (n = 5). Two additional studies were also excluded due to insufficient detail being provided in the text or by the authors, following contact for further clarification. Two additional eligible papers were identified from reference lists and contact with researchers. Forty-seven unique citations were included (Table 1) . Studies were conducted in Europe (n = 30; 63.8%), North America (n = 15; 31.9%), Australia (n = 1; 2.1%) and Asia (n = 1; 2.1%). Relevant data extracted from the studies can be found in Table 2 .
Smoking
Seventeen studies reported smoking information (See Table 2 ). Proportionate meta-analysis revealed that 33% (95% CI = 0.24-0.42; I 2 = 82.4%; total pooled subjects n = 629) of UHR individuals were classed as smokers (Fig. 2) . Furthermore, UHR individuals were more likely to be smokers compared with controls, with a pooled odds ratio of 2.3 (p b 0.05; 95% CI = 1.48-3.48; total pooled subjects n = 938), although substantial heterogeneity was observed between samples (I 2 = 78.8%) (Fig. 3) . Most studies found UHR smokers consumed more cigarettes on average compared with controls (range 5-9 cigarettes per day; median 6). However, many of the studies excluded individuals with substance abuse (Amminger et al., 2010; Auther et al., 2012; Huber et al., 2014; Kristensen and Cadenhead, 2007; Smieskova et al., 2012) , suggesting that the rate of smoking could have been even higher than that reported, given the co-occurrence between smoking and other substance use.
Alcohol use and abuse
Fourteen studies reported information about alcohol use ( Table 2 ). The percentage of people who used alcohol was higher in control groups compared with UHR groups. Current alcohol use varied, ranging from 30% to 88%. Quantity of alcohol consumed per week did not differ between UHR and controls, varying from 1 unit to 8 units (median 6 units).
Ten studies reported alcohol abuse or alcohol use disorders. Comorbid alcohol use disorders were high, reaching up to 38% (Dragt et al., 2012) (Table 2) . Self-reported rates of alcohol abuse ranged from 16% (Huber et al., 2014) to 40% (Hutton et al., 2011) . However, the true prevalence may be higher, as many studies excluded subjects who had current substance abuse or dependence (Amminger et al., 2010; Auther et al., 2012; Bernard et al., 2014; Huber et al., 2014; Kristensen and Cadenhead, 2007; Smieskova et al., 2012) .
Physiological measures
Few studies reported physiological measurements. BMI values among the UHR group in five studies did not significantly differ from healthy controls, and fell within the normal weight range (range = 21-23; median 22); (Amminger et al., 2010; Bernard et al., 2014; Hayes et al., 2014; Labad et al., 2015; Stojanovic et al., 2014) . In one study, systolic blood pressure was significantly lower in UHR subjects than controls, but diastolic blood pressure was no different (Pruessner et al., 2013) . No studies documented blood glucose, cholesterol or lipid levels.
Physical activity levels
Four studies reported physical activity (Deighton and Addington, 2013; Hodgekins et al., 2015; Koivukangas et al., 2010; Mittal et al., 2013) . UHR individuals had consistently lower levels of physical activity (Deighton and Addington, 2013; Hodgekins et al., 2015; Koivukangas Mittal et al., 2013) , and exercised at a lower intensity than controls (Deighton and Addington, 2013; Mittal et al., 2013) . Significantly more UHR individuals engaged in low intensity activity or sedentary behaviour compared with controls (Deighton and Addington, 2013) . UHR males exercised more than females (Deighton and Addington, 2013; Mittal et al., 2013) . A birth cohort study found those who later developed psychosis were more likely to be inactive during adolescence than those who did not (Koivukangas et al., 2010) . UHR individuals reported more barriers to exercise than controls, such as anxiety when exercising ('I do not like how my body looks'), and fewer reasons to exercise than controls (Deighton and Addington, 2013 ).
Physical fitness
Cardiorespiratory fitness was assessed using a Vo2 sub-max cycleergometer test in 4803 adolescents (Koivukangas et al., 2010) . There was no significant difference in cardiorespiratory fitness when individuals were grouped according to at-risk status and amount of prodromal symptoms in adolescence or whether they later developed psychosis (Koivukangas et al., 2010) . However, a separate UHR group reported lower levels of perceived fitness than controls (Deighton and Addington, 2013) .
Diet
One study reported dietary intake, and found UHR individuals consumed significantly more calories than controls (Labad et al., 2015) .
Cardiometabolic risk factors and psychological variables
Low physical activity levels correlated with psychiatric symptoms (Koivukangas et al., 2010) , poor occupational functioning (Mittal et al., (7) 2013) and later development of psychosis (Koivukangas et al., 2010) . Individuals who transitioned to psychosis also smoked more cigarettes on average per day (Labad et al., 2015) , had higher rates of overall cigarette use (Brewer et al., 2003) , consumed more alcoholic units per week (Labad et al., 2015) and had a higher daily calorie intake (Labad et al., 2015) when assessed during the UHR phase. However, overall smoking status was not associated with transition (Brewer et al., 2003; Ziermans et al., 2011) . 
Baseline 46% of a birth cohort who went on to experience psychosis had low physical fitness at adolescence, compared with 33% who did not experience psychosis. 
Discussion
This is the first review assessing cardiometabolic risk factors and physical health in the at-risk population. UHR individuals have high rates of behavioural cardiometabolic risk factors with elevated rates of smoking, physical inactivity and alcohol abuse, but were not more overweight than controls. Longitudinal studies indicate that the increased unhealthy lifestyle factors may be associated with later transition to psychosis. These findings are consistent with a recent meta-analysis that found smoking may be a causative factor in the onset of psychosis (Gurillo et al., 2015) .
Why do UHR individuals have unhealthy lifestyles?
4.1.1. Smoking UHR individuals have high levels of depression, anxiety and negative symptoms (Fusar-Poli et al., 2014; Rietdijk et al., 2013; Yung et al., 2004) . Smoking may reduce these symptoms through relaxation or alleviation of boredom (the self-medication hypothesis) (Kumari and Postma, 2005) . Additionally, nicotine consumption may help to reduce deficits in information processing, by acting on nicotinic receptors in the temporal cortex (Bridgman et al., 2014; De Luca et al., 2004) .
It could be that there is a shared proneness to developing schizophrenia (or sub-threshold psychotic symptoms) and smoking. There may be underlying neurobiological causes for this vulnerability (de Leon and Diaz, 2005) , or it may occur through social mechanisms. For example, it is known that social deprivation increases psychosis risk through social defeat, poverty and increased likelihood of trauma (Allardyce et al., 2005; Cotter et al., 2015) and that socially deprived areas have high rates of unhealthy lifestyle factors including smoking, substance abuse and physical inactivity (Barbeau et al., 2004; Hanson and Chen, 2007; Wardle and Steptoe, 2003) .
Finally, it could be that smoking increases the risk of developing schizophrenia through inducing dopamine dysregulation in the brain (Gurillo et al., 2015) , and the UHR group represents the first manifestation of the illness. However, further research is needed to explain the relationship between smoking and schizophrenia.
Physical inactivity
We can speculate that increased levels of depression, anxiety and negative symptoms in the UHR group contribute to decreased motivation to exercise and increased sedentary behaviour. UHR individuals often report reduced vitality levels, or motivation, energy and drive (Bechdolf et al., 2005; Grano et al., 2014; Hauser et al., 2009; Ruhrmann et al., 2008) . Additionally, as noted above, factors such as social deprivation may present a shared risk for both physical inactivity and schizophrenia (Barbeau et al., 2004) .
Exercise decreases inflammation and increases Brain Derived Neurotrophic Factor (BDNF) (Cotman and Berchtold, 2002; Mondelli et al., 2011; Singh and Chaudhuri, 2014) . We could speculate that there is a link between physical inactivity, increased inflammation and decreased BDNF. However, it is unclear whether a reduction in physical activity has a causative role in increasing inflammation or whether it is a result of underlying neuro-inflammation occurring as the illness progresses.
Alcohol use and diet
Preliminary evidence indicates that UHR individuals may be more likely to abuse alcohol and consume more calories than generally healthy populations. The reported rates of alcohol abuse and misuse were higher than that of the general public. For example, it is estimated that in the UK 3.8% of individuals are alcohol dependent, and 6.8% of young people 16 to 24 years engage in hazardous drinking (McManus et al., 2009 ). Therefore, although many studies did not include a control group, the rates of alcohol abuse were often higher compared with the general population, reaching up to 38% for alcohol abuse (Hutton et al., 2011) and alcohol abuse disorders (Dragt et al., 2012) . We can again speculate that this may be attributable to social and environmental factors, since low socioeconomic status is a common risk factor for psychosis and is also associated with substance misuse and poor diet (Darmon and Drewnowski, 2008; Galea et al., 2004; Marcenko et al., 2000) . However, it could also be that eating a healthy diet has a neuroprotective effect, such as the consumption of omega-3 fatty acids and other vitamins, (McGrath et al., 2004; Peet, 2008) . This arises from recent findings which suggest treatment with long-chain omega-3 fatty acids could lead to longitudinal symptomatic and functional improvements in UHR individuals (Amminger et al., 2010 (Amminger et al., , 2015a (Amminger et al., , 2015b .
Limitations
The scope of the review was intentionally broad. Many studies of varied content and methodological design were included, making direct comparisons difficult. This is also reflected in the high levels of between study heterogeneity reported in the meta-analyses. This is likely to have been driven by both clinical and methodological differences across the studies with regards to UHR screening measures, study inclusion criteria (such as the rates of comorbid disorders and whether those with substance use disorders were included), recruitment settings and methods of data collection. Quality assessments were not conducted, as most information came from demographic assessments and not the studies' primary outcomes. Most studies were cross-sectional and sample size was often underpowered to find significant differences. Control groups varied, sometimes including help-seeking controls which made comparisons difficult.
Clinical implications
High rates of cardiometabolic risk factors observed in the UHR group are due to unhealthy lifestyle factors. These behaviours are potentially modifiable. Thus, the UHR phase is an important opportunity for early intervention to improve physical health, as UHR groups may be amenable to lifestyle interventions, including smoking cessation programmes, exercise promotion and healthy diet. Although a large proportion of UHR individuals will not develop a psychotic disorder, many go on to develop anxiety, mood and substance use disorders (Addington et al., 2011 ) and many will continue to function poorly, regardless of transition or symptomatic remission (Cotter et al., 2014) . Therefore, even among so-called "false positives" (Yung et al., 1996) , interventions to improve physical health are likely to be of benefit and may improve comorbid symptoms such as depression (Cooney et al., 2013) , along with physical health.
Future research
A current gap in the literature is the prevalence and trajectory of plasma measurements of lipid and glucose, and insulin insensitivity in the UHR group. This is of particular interest as it would allow us to examine the possible effects of vulnerability to psychosis on these metabolic markers without confounding effects of antipsychotic medication. Further research is also required in the UHR group to assess cardiometabolic risk factors discussed in this review, such as physical activity and fitness, diet and physiological measurements. Examination of the association between these metabolic and other physical health variables with psychiatric symptoms and transition to psychotic disorder is also of interest and may highlight possible mechanisms underlying the link between unhealthy behaviours and psychosis onset. 
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